Main market
Access this stock data via API
Subscribe
Vicore Pharma Holding AB
0
0
0%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 1.7M 892K 5.1M 0
Cost of revenue
Gross profit 1.7M 892K 5.1M 0
Operating expense
Research & development 99.4M 78.7M 81.6M 49.5M
Selling general and admin 14.1M 14.1M 17.0M 10.9M
Other operating expenses -579K -417K 631K -218K
Operating income -111.2M -91.5M -94.1M -60.1M
Non operating interest income
Income 10.3M 6.4M 10.0M 3.5M
Expense 14.5M 26.4M 1K 3.3M
Other income expense
Pretax income -115.4M -111.5M -84.1M -60.0M
Tax provision 0 0 0 -64K
Net income -115.4M -111.5M -84.1M -59.9M
Basic EPS -0.5 -0.5 -0.4 -0.5
Diluted EPS -0.5 -0.5 -0.4 -0.5
Basic average shares 234.6M 234.6M 216.1M 111.7M
Diluted average shares 234.6M 234.6M 216.1M 111.7M
EBITDA -100.9M -85.1M -84.1M -56.7M
Net income from continuing op. -111.2M -91.5M -94.1M -60.1M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 6 hours 57 minutes

10:32
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).